Fig. 2

Immune molecular functional landscape of glioma subtypes. (A) Differences in immune microenvironment-related scores among subtypes; (B) score distribution of immune cells and immune functions among subtypes; (C) differences in cytolytic scores among subtypes; (D) CIBERSORT immune cell infiltration; (E) distribution of TIDE immunotherapy response between two subtypes; (F) TIDE Scores of Two Subtypes; (G) EXCLUSION scores of two subtypes; (H) dysfunction scores of two subtypes; (I) proportion of CD247 between two subtypes; (J) proportion of CAFs between two subtypes.